RecruitingNCT02594813

Bleeding Rate After EGD and Colonoscopy in Patients Who Continue to Take Antithrombotic Agents


Sponsor

Showa Inan General Hospital

Enrollment

10,000 participants

Start Date

Nov 1, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

The bleeding rate of both EGD (including biopsy) and colonoscopy (including biopsy, cold or hot snare polypectomy, or EMR) in patients who continue to take various antithrombotic drugs is studied prospectively. The immediate or delayed bleeding that requires hemostatic clipping or other endoscopic treatments is defined as the bleeding. Immediate bleeding requiring hemostatic clipping is defined as spurting or oozing which continued for more than 30 seconds. Delayed bleeding is defined as bleeding that requires the endoscopic treatment within 2 weeks after endoscopy. Prophylactic clipping is not performed after taking biopsy and doing polypectomy. Additionally, investigators evaluate the rate of injured submucosal arteries of the excised specimen when the bleeding occurs.


Eligibility

Min Age: 20 YearsMax Age: 90 Years

Exclusion Criteria1

  • Patients who take prophylactic clipping after biopsy or polypectomy American Society of Anesthesiologists physical status of class IV or V

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBiopsy, cold or hot snare polypectomy, or EMR

Locations(1)

Showa Inan General Hospital

Komagane, Japan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02594813


Related Trials